Skip to main content

Aurinia Pharmaceuticals Inc 10-K for FY2025

Aurinia Pharmaceuticals Inc. (AUPH)

10-K 2026-02-26 For: 2025-12-31
View Original
Added on April 04, 2026

About this 10-K

Aurinia Pharmaceuticals Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$283.06M
up 20.4% from $235.13M a year earlier
Net income
$287.2M
up 4893.1% from net income of $5.75M a year earlier
Diluted EPS
$2.07
up 5075.0% from $0.04 a year earlier